JP5116971B2 - Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用 - Google Patents

Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用 Download PDF

Info

Publication number
JP5116971B2
JP5116971B2 JP2005501294A JP2005501294A JP5116971B2 JP 5116971 B2 JP5116971 B2 JP 5116971B2 JP 2005501294 A JP2005501294 A JP 2005501294A JP 2005501294 A JP2005501294 A JP 2005501294A JP 5116971 B2 JP5116971 B2 JP 5116971B2
Authority
JP
Japan
Prior art keywords
fbsa
polypeptide
fibrinogen
gbs
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005501294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520583A (ja
Inventor
ディーター ヨット． レインシェイド
ハイケ グーテクンスト
アクセル シューベルト
ベルンハルド ヨット． エイクマンズ
アンドレアス ミンク
Original Assignee
インターセル アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターセル アーゲー filed Critical インターセル アーゲー
Publication of JP2006520583A publication Critical patent/JP2006520583A/ja
Application granted granted Critical
Publication of JP5116971B2 publication Critical patent/JP5116971B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2005501294A 2002-10-15 2003-10-15 Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用 Expired - Fee Related JP5116971B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP02023141.1 2002-10-15
EP02023141 2002-10-15
EP03006393.7 2003-03-20
EP03006393 2003-03-20
PCT/EP2003/011436 WO2004035618A2 (en) 2002-10-15 2003-10-15 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010051266A Division JP2010207219A (ja) 2002-10-15 2010-03-09 Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用

Publications (2)

Publication Number Publication Date
JP2006520583A JP2006520583A (ja) 2006-09-14
JP5116971B2 true JP5116971B2 (ja) 2013-01-09

Family

ID=32109135

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2005501294A Expired - Fee Related JP5116971B2 (ja) 2002-10-15 2003-10-15 Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
JP2010051266A Pending JP2010207219A (ja) 2002-10-15 2010-03-09 Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
JP2013138528A Pending JP2014003979A (ja) 2002-10-15 2013-07-02 Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010051266A Pending JP2010207219A (ja) 2002-10-15 2010-03-09 Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
JP2013138528A Pending JP2014003979A (ja) 2002-10-15 2013-07-02 Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用

Country Status (7)

Country Link
US (3) US7485710B2 (de)
EP (3) EP1551869A2 (de)
JP (3) JP5116971B2 (de)
CN (2) CN102174533A (de)
AU (2) AU2003274011B2 (de)
CA (1) CA2502414A1 (de)
WO (1) WO2004035618A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939087B2 (en) 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
WO2004018646A2 (en) * 2002-08-26 2004-03-04 Chiron Corporation Conserved and specific streptococcal genomes
JP5116971B2 (ja) 2002-10-15 2013-01-09 インターセル アーゲー Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
US7709009B2 (en) * 2003-07-31 2010-05-04 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2005076827A2 (en) * 2004-02-04 2005-08-25 Universita' Degli Studi Di Pavia Fbsa compositions for use in promoting fibrinogen aggregation and potentiating fibrin polymerization
WO2006078318A2 (en) 2004-07-29 2006-07-27 Novartis Vaccines And Diagnostics Inc. Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
EP1807446A2 (de) * 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogene und therapeutische zusammensetzungen für pyogene streptokokken
EP1828231A2 (de) * 2004-12-22 2007-09-05 Novartis Vaccines and Diagnostics, Inc. Streptokokkus der gruppe b
WO2006074675A1 (de) * 2004-12-23 2006-07-20 Daimlerchrysler Ag Rückhaltevorrichtung für einen insassen eines fahrzeugs
US8401159B2 (en) * 2005-11-30 2013-03-19 On-Q Telecom Systems Co., Inc. Data provision to a virtual personal assistant for handling calls in a communication system
DK2054431T3 (da) * 2006-06-09 2012-01-02 Novartis Ag Konformere af bakterielle adhæsiner
AU2007348285A1 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
EP2266592A3 (de) 2007-01-12 2012-08-08 Intercell AG Schützende Proteine von S. agalactiae, Kombinationen davon und Verwendungsverfahren dafür
US8287885B2 (en) 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
NZ586430A (en) 2007-12-21 2012-09-28 Novartis Ag Mutant forms of streptolysin o (slo)
AU2009206506B2 (en) * 2008-01-23 2013-01-10 Xencor, Inc. Optimized CD40 antibodies and methods of using the same
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
CN108840914B (zh) * 2018-08-13 2022-07-01 内蒙古民族大学 一种具有免疫原性的多肽、其抗体的制备方法以及用途
CN111690584A (zh) * 2020-06-16 2020-09-22 中国水产科学研究院珠江水产研究所 重组乳酸乳球菌和罗非鱼无乳链球菌病疫苗
CN121108327B (zh) * 2025-11-14 2026-01-27 北京市华信行生物科技有限公司 B族链球菌表面免疫原性蛋白单克隆抗体及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ATE318832T1 (de) 1990-06-11 2006-03-15 Gilead Sciences Inc Verfahren zur vervendung von nukleinsäureliganden
EP0464533B1 (de) 1990-06-28 1998-07-29 Hoechst Aktiengesellschaft Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung
US5858725A (en) 1990-10-10 1999-01-12 Glaxo Wellcome Inc. Preparation of chimaeric antibodies using the recombinant PCR strategy
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
GB9022543D0 (en) 1990-10-17 1990-11-28 Wellcome Found Antibody production
GB9022547D0 (en) 1990-10-17 1990-11-28 Wellcome Found Purified immunoglobulin
GB9122820D0 (en) 1991-10-28 1991-12-11 Wellcome Found Stabilised antibodies
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
FR2735478B1 (fr) * 1995-06-13 1997-08-22 Pasteur Institut Molecules polypeptidiques de stade pre-erythrocytaire du paludisme
CO4600681A1 (es) 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma Composicion farmaceutica para la modulacion inmunitaria
ES2188985T3 (es) 1996-08-30 2003-07-01 Jens Peter Furste Seleccion enantiomerica y evolucion enantiomerica de acidos nucleicos.
US5910441A (en) * 1996-09-16 1999-06-08 The Rockefeller University DNA encoding fibronectin and fibrinogen binding protein from group A streptococci
US5849902A (en) 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US5989912A (en) 1996-11-21 1999-11-23 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
DE19803453A1 (de) 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
US7098182B2 (en) * 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
GB9816335D0 (en) * 1998-07-27 1998-09-23 Cortecs Uk Ltd Proteins
WO2000006736A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
CA2366152A1 (en) * 1999-03-19 2000-09-28 Smithkline Beecham Biologicals S.A. Streptococcus pneumoniae vaccine
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
AT409085B (de) 2000-01-28 2002-05-27 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
HU228264B1 (en) 2000-06-08 2013-02-28 Intercell Ag Immunostimulatory oligodeoxynucleotides
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
AU2001289813B2 (en) 2000-08-17 2005-07-28 Intercell Ag A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
US7939087B2 (en) * 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
JP5116971B2 (ja) 2002-10-15 2013-01-09 インターセル アーゲー Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用

Also Published As

Publication number Publication date
CN1705679A (zh) 2005-12-07
WO2004035618A2 (en) 2004-04-29
CA2502414A1 (en) 2004-04-29
US20100113340A1 (en) 2010-05-06
US7960533B2 (en) 2011-06-14
AU2003274011A1 (en) 2004-05-04
CN1705679B (zh) 2011-04-06
JP2010207219A (ja) 2010-09-24
JP2014003979A (ja) 2014-01-16
EP2314604A2 (de) 2011-04-27
US7485710B2 (en) 2009-02-03
EP2314603A3 (de) 2011-05-18
EP2314603A2 (de) 2011-04-27
AU2003274011B2 (en) 2010-03-04
EP2314604A3 (de) 2011-05-25
US8318908B2 (en) 2012-11-27
US20060115479A1 (en) 2006-06-01
US20110287013A1 (en) 2011-11-24
CN102174533A (zh) 2011-09-07
WO2004035618A3 (en) 2004-09-30
JP2006520583A (ja) 2006-09-14
AU2010201016B2 (en) 2012-06-14
EP1551869A2 (de) 2005-07-13
AU2010201016A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
JP2014003979A (ja) Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
JP2000512487A (ja) 新規化合物
JP2000509974A (ja) 新規化合物
TW201021845A (en) Prevention, treatment and diagnosis of P. gingivalis infection
JP2001508650A (ja) 新規細菌ポリペプチドおよびポリヌクレオチド
US8529912B2 (en) Group B Streptococcus polypeptides, nucleic acids and therapeutic compositions and vaccines thereof
US20130243779A1 (en) Peptides protective against e. faecalis, methods and uses relating thereto
JPH11103871A (ja) 新規化合物
US20100221277A1 (en) Chlamydia pneumoniae antigens
JPH10201484A (ja) 新規ＦｔｓＬ
JP2001504682A (ja) 新規化合物
JP2000509984A (ja) 新規化合物
JP2000500326A (ja) フィブロネクチン結合タンパク質ｂ化合物
JP2002272487A (ja) 新規ｐｃｒＡ
JP2002253274A (ja) 新規化合物
JP2001509682A (ja) 新規ストレプトコッカスｅｒｓ
JP2000504207A (ja) スタフィロコッカス・アウレウス由来の２成分シグナルトランスダクション応答レギュレーターポリペプチド
JP2000509985A (ja) 新規化合物
JPH10290693A (ja) 新規フィブロネクチン結合蛋白化合物
JP2001505421A (ja) 新規ＦａｂＤ
JP2002119292A (ja) 新規ｖａｌＳ
JPH10229886A (ja) ｓｐｏ／ｒｅｌ
JP2000102385A (ja) ｄｅｆ１

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061010

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090909

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091201

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110511

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110518

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110615

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120613

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120613

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120704

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120919

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121017

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151026

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees